Compare
Merck & vs Zoetis (MRK vs ZTS)
The two stocks side by side, as of the latest close. Performance is rebased to 100 at the start of the window.
Over the past year Merck & (MRK) returned +73.9% and Zoetis (ZTS) -34.1%; so far this year the figures are +39.4% and -36.9%.
Merck & is the larger company by market value, about 11.2 times the size of Zoetis.
On trailing earnings, MRK trades at 149.7 times and ZTS at 13.4 times.
Revenue grew +4.9% at MRK and +0.9% at ZTS over the last year.
MRK yields 2.32%. ZTS yields 2.67%.
Data as of the latest close. Not investment advice.
Relative performance
| MRK | ZTS | |
|---|---|---|
| Price | $146.73 | $79.40 |
| 1-day | -0.14% | -3.30% |
| YTD | +39.40% | -36.89% |
| 1 year | +73.87% | -34.10% |
| 3 years | +42.66% | -47.57% |
| Market cap | $361.7B | $32.3B |
| P/E | 149.7 | 13.4 |
| P/S | 5.37 | 3.40 |
| P/B | 8.06 | 9.77 |
| Revenue growth | +4.90% | +0.90% |
| EPS growth | -87.10% | +0.70% |
| Gross margin % | 71.8 | 71.6 |
| Net margin % | 3.6 | 26.4 |
| ROE % | 5.5 | 75.9 |
| Debt / equity | 1.20 | 2.74 |
| FCF yield % | 4.1 | 6.9 |
| Dividend yield % | 2.32 | 2.67 |
| Beta | 0.18 | 0.59 |
| RSI (14) | 51.3 | 51.1 |
| Technical rating |